Laquinimod (sodium), CAS [[248282-07-7]] Preis auf Anfrage

Produktübersicht

• Artikelname: Laquinimod (sodium), CAS [[248282-07-7]] Preis auf Anfrage
• Artikelnummer: MCE-HY-W062904
• Hersteller Artikelnummer: HY-W062904
• Alternativnummer: MCE-HY-W062904-1UNIT
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: ABR-215062 (sodium)

Produktbeschreibung

Laquinimod (ABR-215062) sodium, an orally available carboxamide derivative, is a potent immunomodulator which prevents neurodegeneration and inflammation in the central nervous system. Laquinimod sodium reduces astrocytic NF-kappaB activation to protect from Cuprizone-induced demyelination. Laquinimod sodium has the potential for relapsing remitting (RR) and chronic progressive (CP) forms of multiple sclerosis (MS, RRMS or CPMS) as well as neurodegenerative diseases research[1][2][3][4].

Produkteigenschaften

• Molekulargewicht: 379.79
• CAS Nummer: [248282-07-7]
• Formel: C19H17ClN2NaO3
• Target-Kategorie: Apoptosis,NF-kappaB

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound